Headless WordPress - PROD

Novel approaches offer new hope for reducing exacerbations and improving lung function

https://www.sharecare.com/hcp/lung-health/emerging-therapies-copd-management

Breaking New Ground: Emerging Therapies for COPD Management|Beyond Bronchodilation: How Biologic Therapies Are Redefining COPD Management|From Asthma to COPD: Expanding the Role of Biologic Therapies|The Future of COPD Care: Targeting Inflammation for Long-Term Disease Control

Breaking new ground: emerging therapies for COPD management

Targeting inflammation offers a new pathway for improving patient outcomes

https://www.sharecare.com/hcp/lung-health/biologic-therapies-redefining-copd-management

Beyond Bronchodilation: How Biologic Therapies Are Redefining COPD Management

Beyond bronchodilation: how biologic therapies are redefining COPD management

Medications initially approved for other inflammatory diseases are now reshaping COPD management

https://www.sharecare.com/hcp/lung-health/copd-expanding-role-biologic-therapies

From Asthma to COPD: Expanding the Role of Biologic Therapies

From asthma to COPD: expanding the role of biologic therapies

Advancements in biologics, PDE4 inhibitors, and regenerative medicine shape the next era of COPD treatment

https://www.sharecare.com/hcp/lung-health/targeting-inflammation-long-term-copd-control

The Future of COPD Care: Targeting Inflammation for Long-Term Disease Control

The future of COPD care: targeting inflammation for long-term disease control

Featured Content

Dx Dialogues: Chronic Obstructive Pulmonary Disease

In this video, Dr. Michael Czarnecki, Pulmonary and Critical Care physician, explores key developments in the evolving treatment of COPD. He reviews historical approaches to care and highlights the impact of triple therapy in managing symptoms and exacerbations. Dr. Czarnecki also discusses emerging therapies, including monoclonal antibodies and biologics, emphasizing their potential to reduce inflammation, improve lung function, and lower the risk of exacerbations. He underscores the importance of staying current with advancements in COPD management to optimize patient outcomes.